Five-day infusion fluorouracil plus vinorelbine i.v. in metastatic pretreated breast cancer patients.
- 1 July 1997
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 44 (3) , 255-260
- https://doi.org/10.1023/a:1005769604001
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Vinorelbine: An active, non cross-resistant drug in advanced breast cancer. Results from a phase II studyBreast Cancer Research and Treatment, 1996
- Infusional 5-fluorouracil in breast cancerCancer Treatment Reviews, 1994
- Vinorelbine (Navelbine) as a salvage treatment for advanced breast cancerAnnals of Oncology, 1994
- Back to the basics: the importance of concentration x time in oncology.Journal of Clinical Oncology, 1993
- 5-Fluorouracil by Protracted Venous Infusion: A Review of Recent Clinical StudiesCancer Investigation, 1991
- Continuous Intravenous Infusion of 5-Fluorouracil in the Treatment of Refractory Breast CancerAmerican Journal of Clinical Oncology, 1989
- 5-fluorouracil rechallenge by protracted infusion in refractory breast cancerCancer, 1989
- Low-dose continuous infusion 5-fluorouracil. Evaluation in advanced breast carcinomaCancer, 1989